Cargando…
Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, and CD4(+) T cells form the core immunopathogenic cascade leading to chronic inflammation. Traditionally, Th1 cells (interferon-γ-producing CD4(+) T cells) driven by interleukin 12 (IL12) were considered to be the enceph...
Autores principales: | Chen, Shyi-Jou, Wang, Yen-Ling, Fan, Hueng-Chuen, Lo, Wen-Tsung, Wang, Chih-Chien, Sytwu, Huey-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235500/ https://www.ncbi.nlm.nih.gov/pubmed/22203863 http://dx.doi.org/10.1155/2012/970789 |
Ejemplares similares
-
Immunologic Regulation in Pregnancy: From Mechanism to Therapeutic Strategy for Immunomodulation
por: Chen, Shyi-Jou, et al.
Publicado: (2012) -
Current Proceedings of Childhood Stroke
por: Fan, Hueng-Chuen, et al.
Publicado: (2011) -
Vaccines – beliefs and concerns: the voice of patients with inflammatory immunomediated diseases
por: Abreu, Cândida, et al.
Publicado: (2023) -
Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
por: Chen, Shyi-Jou, et al.
Publicado: (2019) -
Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2023)